DE2519730C2 - - Google Patents
Info
- Publication number
- DE2519730C2 DE2519730C2 DE2519730A DE2519730A DE2519730C2 DE 2519730 C2 DE2519730 C2 DE 2519730C2 DE 2519730 A DE2519730 A DE 2519730A DE 2519730 A DE2519730 A DE 2519730A DE 2519730 C2 DE2519730 C2 DE 2519730C2
- Authority
- DE
- Germany
- Prior art keywords
- group
- compounds
- parts
- formula
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C66/00—Quinone carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/001—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
- C07C37/002—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by transformation of a functional group, e.g. oxo, carboxyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/50—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions decreasing the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with no unsaturation outside the aromatic ring
- C07C39/11—Alkylated hydroxy benzenes containing also acyclically bound hydroxy groups, e.g. saligenol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/54—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C46/00—Preparation of quinones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C46/00—Preparation of quinones
- C07C46/02—Preparation of quinones by oxidation giving rise to quinoid structures
- C07C46/06—Preparation of quinones by oxidation giving rise to quinoid structures of at least one hydroxy group on a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/28—Quinones containing groups having oxygen atoms singly bound to carbon atoms with monocyclic quinoid structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/38—Quinones containing —CHO or non—quinoid keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
- C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
- 1) Alle Verbindungen der Formel (I) haben eine ausgezeichnete Wirkung auf die Lysosomenmembranen der Zelle und auf die wirtseigenen Kontrollmechanismen zur Abwehr von Pathogenen, insbesondere eine immunitätsverstärkende Wirkung. Sie eignen sich somit als Arzneimittel für die Therapie von Mensch und Tier.
- 2) Diese Verbindungen sind sämtlich einfach in der chemischen Struktur und eignen sich für die Großherstellung.
- 3) Die Verbindungen sind in ausreichendem Maße hydrophil und lassen sich einfach zu pharmazeutischen Produkten formulierenn.
- 4) Die Verbindungen sind verhältnismäßig beständig gegen Säuren und Licht und können vorteilhaft als Arzneimittel verwendet werden.
8,31 (CH₂, Multiplett), 8,07 (CH₃, Singlett), 7,63 (CH₂CO, Multiplett), 7,35 (COCH₂, Multiplett), 6,01 (OCH₃, Singlett).
Berechnet für C₁₅H₁₈O₇:
C 58,06; H 5,85.
Gefunden:
C 57,89; H 5,90.
8,8-8,1 (CH₂, Multiplett), 8,00 (Ring-CH₃, Singlett), 7,9-7,3 (CH₂, Multiplett).
Berechnet für C₁₅H₂₀O₄:
C 68,16; H 7,63.
Gefunden:
C 68,19; H 7,61.
8,9-8,1 (CH₂, Multiplett), 7,98 (Ring-CH₃, Singlett), 7,9-7,3 (CH₂, Multiplett).
Berechnet für C₁₆H₂₂O₄:
C 69,04; H 7,97.
Gefunden:
C 69,08; H 8,04.
8,9-8,1 (CH₂, Multiplett), 8,0 (Ring-CH₃, Singlett), 8,0-7,3 (CH₂, Multiplett).
Berechnet für C₁₉H₂₈O₄:
C 71,22; H 8,81.
Gefunden:
C 71,19; H 8,80.
8,82-8,25 (CH₂, Multiplett), 8,00 (Ring-CH₃, Singlett), 7,65 (Ring-CH₂, CH₂CO, Triplett), 6,03 (OCH₃, Singlett), 0,22 (COOH, breit).
Berechnet für C₁₉H₂₈O₆:
C 64,75; H 8,01.
Gefunden:
C 64,69; H 8,11.
8,73-8,20 (CH₂, Multiplett), 7,97 (Ring-CH₃, Singlett), 7,60 (Ring-CH₂, CH₂CO, Triplett), 6,00 (OCH₃, Singlett), -0,55 (COOH, breit).
Berechnet für C₁₅H₂₀O₆:
C 60,80; H 6,80.
Gefunden:
C 60,60; H 6,81.
Berechnet für C₁₃H₁₆O₆:
C 58,20; H 6,01.
Gefunden:
C 58,03; H 5,77.
Berechnet für C₂₀H₃₀O₆:
C 65,55; H 8,25.
Gefunden:
C 65,44; H 8,36.
8,76 (CH₃, Triplett), 8,66 (CH₂, breit), 8,04 (Ring-CH₃), Singlett), 7,77 (Ring-CH₂, Triplett), 7,80-7,37 (CH₂COO, breit), 6,05 (CH₃O, Singlett), 5,95 (COOCH₂, Quartett).
Berechnet für C₂₀H₃₀O₆:
C 65,55; H 8,25.
Gefunden:
C 65,02; H 8,07.
Berechnet für C₁₈H₂₆O₆:
C 63,88; H 7,74.
Gefunden:
C 63,60; H 7,88.
8,02 (Ring-CH₃, Singlett), 7,95 (Ring-CH₃, Singlett), 7,53 (CH₂COO, Triplett), 7,18 (Ring-CH₂, Triplett), 6,50 (COOCH₃, Singlett)
Berechnet für C₁₂H₁₄O₄:
C 64,85; H 6,35.
Gefunden:
C 64,84; H 6,32.
Berechnet für C₁₂H₁₄O₆:
C 56,69; H 5,55.
Gefunden:
C 56,91; H 5,24.
8,74 (CH₃, Triplett), 8,56-8,00 (CH₂, Multiplett), 7,96 (Ring-CH₃), Singlett), 7,65 (CH₂COO, Triplett), 7,46 (Ring-CH₃, Triplett), 5,99 (OCH₃, Singlett), 5,86 (COOCH₂, Quartett)
Berechnet für C₁₅H₂₀O₆:
C 60,80; H 6,80.
Gefunden:
C 61,26; H 7,12.
8,76 (CH₃, Triplett), 8,80-8,30 (CH₂, Multiplett), 8,0 (Ring-CH₃, Singlett), 8,00-7,30 (Ring-CH₂, CH₂COO, Multiplett), 5,88 (COOCH₂, Quartett)
Berechnet für C₁₇H₂₄O₄:
C 69,83; H 8,27.
Gefunden:
C 69,85; H 8,36.
A. Kapseln | |
1) 2,3-Dimethoxy-5-methyl-6-(3′-ethoxycarbonylpropyl)-1,4-benzochinon|20 mg | |
2) Maisöl | 150 mg |
170 mg | |
pro Kapsel |
B. Tabletten | |
1) 2,3,5-Trimethyl-6-(5′-carboxypentyl)-1,4-benzochinon|20 mg | |
2) Lactose | 35 mg |
3) Maisstärke | 150 mg |
4) mikrokristalline Cellulose | 30 mg |
5) Magnesiumstearat | 5 mg |
240 mg | |
pro Tablette |
C. Injektionslösung | |
a) 1) 2,3-Dimethoxy-5-methyl-6-(2′-carboxyethyl)-1,4-benzochinon|10 mg | |
2) Natriumbicarbonat | 3,3 mg |
3) Natriumchlorid | 0,018 mg |
b) 1) 2,3-Dimethoxy-5-methyl-6-(5′-carboxy-1′-oxopentyl)-1,4-benzochinon|10 mg | |
2) Natriumbicarbonat | 2,7 mg |
3) Natriumchlorid | 0,018 mg |
Claims (4)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP49050003A JPS5919930B2 (ja) | 1974-05-02 | 1974-05-02 | キノン酸誘導体の製造法 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE2519730A1 DE2519730A1 (de) | 1975-11-20 |
DE2519730C2 true DE2519730C2 (de) | 1990-06-07 |
Family
ID=12846811
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2560550A Expired DE2560550C2 (de) | 1974-05-02 | 1975-05-02 | Benzochinonderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
DE19752519730 Granted DE2519730A1 (de) | 1974-05-02 | 1975-05-02 | Benzochinonderivate, verfahren zu ihrer herstellung und ihre verwendung |
DE2560549A Expired - Lifetime DE2560549C2 (de) | 1974-05-02 | 1975-05-02 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2560550A Expired DE2560550C2 (de) | 1974-05-02 | 1975-05-02 | Benzochinonderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2560549A Expired - Lifetime DE2560549C2 (de) | 1974-05-02 | 1975-05-02 |
Country Status (6)
Country | Link |
---|---|
US (2) | US4139545A (de) |
JP (1) | JPS5919930B2 (de) |
BE (1) | BE828622A (de) |
DE (3) | DE2560550C2 (de) |
FR (2) | FR2269333B1 (de) |
GB (1) | GB1512541A (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4208331A (en) * | 1977-05-17 | 1980-06-17 | Hoffmann-La Roche Inc. | Synthesis of optically active vitamin E |
US4533554A (en) * | 1979-05-18 | 1985-08-06 | Takeda Chemical Industries, Ltd. | Quinone derivatives and use |
JPS5640651A (en) * | 1979-09-12 | 1981-04-16 | Takeda Chem Ind Ltd | Quinone compound and its preparation |
JPS567734A (en) * | 1979-06-28 | 1981-01-27 | Takeda Chem Ind Ltd | Preparation of quinone derivative |
JPS56147746A (en) * | 1980-04-15 | 1981-11-16 | Takeda Chem Ind Ltd | Quinones and their preparation |
DE3069496D1 (de) * | 1979-06-28 | 1984-11-29 | Takeda Chemical Industries Ltd | 2,3-dialkoxy-1,4-quinone derivatives; method of producing 1,4-quinone derivatives |
JPS567737A (en) * | 1979-07-02 | 1981-01-27 | Takeda Chem Ind Ltd | Physiologically active quinone and its preparation |
JPS5697223A (en) | 1979-12-30 | 1981-08-05 | Takeda Chem Ind Ltd | Tissue metabolism activator |
DE3010474A1 (de) * | 1980-03-19 | 1981-10-01 | Basf Ag, 6700 Ludwigshafen | 4-(dihydroxyphen-l-yl)-crotonsaeure und deren derivate sowie verfahren zur herstellung dieser verbindungen |
US4393075A (en) * | 1980-04-14 | 1983-07-12 | Takeda Chemical Industries, Ltd. | Quinone compounds and their use in suppressing the production of SRS-A in mammals |
JPS56150014A (en) * | 1980-04-21 | 1981-11-20 | Takeda Chem Ind Ltd | Antiallergic agent |
JPS57131735A (en) * | 1981-02-09 | 1982-08-14 | Takeda Chem Ind Ltd | Preparation of quinones |
CA1247632A (en) * | 1981-06-19 | 1988-12-28 | Frederick H. Howell | Hydroquinones |
JPS58174313A (ja) * | 1982-04-06 | 1983-10-13 | Takeda Chem Ind Ltd | 動物組織の線維化抑制剤 |
JPS58177934A (ja) * | 1982-04-13 | 1983-10-18 | Takeda Chem Ind Ltd | ベンゾキノン誘導体 |
US4808339A (en) * | 1982-04-13 | 1989-02-28 | Takeda Chemical Industries, Ltd. | Benzoquinone derivatives |
EP0098241B1 (de) * | 1982-06-16 | 1985-10-02 | Ciba-Geigy Ag | Hydrochinonäther und ein Verfahren zu deren Herstellung |
JPS59204167A (ja) * | 1983-05-02 | 1984-11-19 | Takeda Chem Ind Ltd | ヒドロキノン誘導体およびその製法 |
US5220042A (en) * | 1984-01-26 | 1993-06-15 | Otsuka Pharmaceutical Co., Ltd. | 1,4-benzoquinone derivatives and benzene derivatives, and process for preparing the same |
MX9203040A (es) * | 1984-08-01 | 1992-07-31 | Takeda Chemical Industries Ltd | Derivados de quinona y composicion farmaceutica que los contiene. |
US5304658A (en) * | 1984-08-01 | 1994-04-19 | Takeda Chemical Industries, Ltd. | Quinone derivatives, their production and use |
DE3680023D1 (de) * | 1985-04-08 | 1991-08-08 | Takeda Chemical Industries Ltd | Benzochinonderivate, ihre herstellung und verwendung. |
ATE80141T1 (de) * | 1987-04-27 | 1992-09-15 | Takeda Chemical Industries Ltd | Reduktion von carbonsaeureestern. |
DE4034420A1 (de) * | 1990-10-29 | 1992-04-30 | Biotechnolog Forschung Gmbh | Neue w-(1,4-chinonyl)-alkanale, herstellungsverfahren und verwendung |
JP2947503B2 (ja) * | 1994-03-02 | 1999-09-13 | エーザイ株式会社 | アリルキノン誘導体の製造方法および中間体 |
EP0788793A1 (de) | 1996-02-01 | 1997-08-13 | Takeda Chemical Industries, Ltd. | Idebenon zur Behandlung von Demenz |
AR053665A1 (es) * | 2006-01-23 | 2007-05-16 | Creactivar S A | Uso de la mimosina o un derivado de la misma, en el tratamiento de las manifestaciones cutaneas de la psoriasis y de los desordenes cutaneos relacionados con esta y una composicion cosmetica o farmaceutica que la comprende |
DK2605769T3 (en) | 2010-08-16 | 2016-10-24 | Santhera Pharmaceuticals (Schweiz) Ag | Benzoquinonderivater for the treatment of mitochondrial diseases of the eye |
EP2606022A2 (de) * | 2010-08-16 | 2013-06-26 | Santhera Pharmaceuticals (Schweiz) AG | Neuartige benzochinonderivate und ihre verwendung als modulatoren der mitochondrienfunktion |
WO2014012009A1 (en) | 2012-07-12 | 2014-01-16 | Concert Pharmaceuticals, Inc. | Deuterated idebenone |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1192466A (en) * | 1967-09-01 | 1970-05-20 | Eastman Kodak Co | Improvements in Heat Sensitive Copying Materials |
DE2112147A1 (de) * | 1970-03-17 | 1971-09-30 | Takeda Chemical Industries Ltd | Chinonderivate und Verfahren zu ihrer Herstellung |
US3849453A (en) * | 1970-03-17 | 1974-11-19 | Takeda Chemical Industries Ltd | Quinone derivatives |
-
1974
- 1974-05-02 JP JP49050003A patent/JPS5919930B2/ja not_active Expired
-
1975
- 1975-04-30 FR FR7513628A patent/FR2269333B1/fr not_active Expired
- 1975-04-30 BE BE155984A patent/BE828622A/xx not_active IP Right Cessation
- 1975-04-30 US US05/573,158 patent/US4139545A/en not_active Expired - Lifetime
- 1975-05-02 DE DE2560550A patent/DE2560550C2/de not_active Expired
- 1975-05-02 DE DE19752519730 patent/DE2519730A1/de active Granted
- 1975-05-02 GB GB18538/75A patent/GB1512541A/en not_active Expired
- 1975-05-02 DE DE2560549A patent/DE2560549C2/de not_active Expired - Lifetime
-
1976
- 1976-02-11 FR FR7603788A patent/FR2293194A1/fr active Granted
-
1983
- 1983-05-23 US US06/497,014 patent/US4525361A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FR2293194B1 (de) | 1978-12-15 |
JPS5919930B2 (ja) | 1984-05-09 |
GB1512541A (en) | 1978-06-01 |
DE2519730A1 (de) | 1975-11-20 |
JPS50148325A (de) | 1975-11-27 |
US4139545A (en) | 1979-02-13 |
US4525361A (en) | 1985-06-25 |
FR2269333B1 (de) | 1978-08-04 |
DE2560549C2 (de) | 1990-08-16 |
DE2560550C2 (de) | 1987-05-14 |
BE828622A (fr) | 1975-10-30 |
FR2293194A1 (fr) | 1976-07-02 |
FR2269333A1 (de) | 1975-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2519730C2 (de) | ||
DE2636582C2 (de) | 2-Amino-3-(5- und 6-)benzoylphenylessigsäuren, deren Ester und Metallsalze, Verfahren zur Herstellung dieser Verbindungen und Arzneimittel diese enthaltend | |
DE1445154C3 (de) | 1,4-Dihydro-1,8-naphthyridinderi vate und ein Verfahren zu ihrer Herstellung | |
DE2228012C3 (de) | Phthalidester der 6- [D(-)- a Aminophenylacetamido] -penicillansäure und Verfahren zu seiner Herstellung | |
DE2431198C2 (de) | Chinonderivate und sie enthaltende pharmazeutische Zubereitungen | |
DE2419970B2 (de) | ||
DE1795613B2 (de) | Indolylessigsaeuren, verfahren zu ihrer herstellung und arzneimittel | |
DE2141634C3 (de) | Neue Isoindolinderivate, ihre Herstellung und Zusammensetzungen, die sie enthalten | |
EP0258729A2 (de) | Dihydropyridinverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung | |
DE2941869C2 (de) | ||
EP0006114A1 (de) | 7-Methoxy-5-oxo-5H-thiazolo(2,3-b)chinazolin-2-carbonsäure und deren pharmazeutisch verwendbare Salze. Verfahren zu deren Herstellung und sie enthaltende Arzneimittel | |
DE2007345A1 (de) | Neue substituierte Hexahydroimidazochinoline und deren Säureanlagerungssalze | |
DE2812353A1 (de) | Oxazol- und thiazol-alkansaeureverbindungen, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel | |
DE2122485A1 (de) | Verfahren zur Herstellung von Aminen | |
EP0027268A2 (de) | Chinazolin-Derivate, Verfahren und Zwischenprodukte zu deren Herstellung, Arzneimittel enthaltend solche Chinazolin-Derivate und deren pharmazeutische Verwendung | |
EP0313935B1 (de) | Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
EP0033066A2 (de) | Penicillinderivate, Zwischenprodukte für ihre Herstellung, pharmazeutische Präparate enthaltend dieselben, ihre Herstellung, sowie ihre Verwendung | |
DE3632893A1 (de) | 4-(r)-hydroxy-6(s)-arylthiomethyl-tetrahydropyran-2-one, deren entsprechende sulfoxide und sulfone, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte | |
DE1804983A1 (de) | Verfahren zur Herstellung von Cephalosporansaeurederivaten | |
DE2004301A1 (de) | Phenylserinderivate | |
DE3347657A1 (de) | Neue 1,4-naphthochinonderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE3034005C2 (de) | Indolessigsäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen | |
DE2917890C2 (de) | ||
DE2906253A1 (de) | Furonaphthyridinverbindungen und arzneimittel | |
EP0095641A1 (de) | Chinazolinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8110 | Request for examination paragraph 44 | ||
8126 | Change of the secondary classification |
Free format text: C07C 39/11 C07C 49/82 C07C 50/32 C07C 59/52 C07C 59/76 A61K 31/12 A61K 31/19 |
|
8172 | Supplementary division/partition in: |
Ref country code: DE Ref document number: 2560550 Format of ref document f/p: P |
|
Q171 | Divided out to: |
Ref country code: DE Ref document number: 2560550 |
|
8172 | Supplementary division/partition in: |
Ref country code: DE Ref document number: 2560549 Format of ref document f/p: P |
|
Q171 | Divided out to: |
Ref country code: DE Ref document number: 2560549 |
|
AH | Division in |
Ref country code: DE Ref document number: 2560550 Format of ref document f/p: P |
|
AH | Division in |
Ref country code: DE Ref document number: 2560550 Format of ref document f/p: P Ref country code: DE Ref document number: 2560549 Format of ref document f/p: P |
|
D2 | Grant after examination | ||
AH | Division in |
Ref country code: DE Ref document number: 2560549 Format of ref document f/p: P |
|
8364 | No opposition during term of opposition |